Addus HomeCare (NASDAQ:ADUS) Given New $136.00 Price Target at Royal Bank of Canada

Addus HomeCare (NASDAQ:ADUS) had its target price reduced by Royal Bank of Canada from $141.00 to $136.00 in a research note published on Wednesday morning, Benzinga reports. They currently have an outperform rating on the stock.

Other analysts have also recently issued reports about the stock. Macquarie restated an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a report on Monday. TD Cowen lifted their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Oppenheimer boosted their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. KeyCorp initiated coverage on Addus HomeCare in a report on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective for the company. Finally, Stephens restated an “overweight” rating and issued a $138.00 target price on shares of Addus HomeCare in a research note on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $131.63.

Addus HomeCare Stock Up 5.5 %

ADUS opened at $130.96 on Wednesday. The firm has a market capitalization of $2.37 billion, a P/E ratio of 29.97, a PEG ratio of 2.29 and a beta of 1.04. The stock has a fifty day moving average of $129.75 and a 200-day moving average of $120.92. Addus HomeCare has a 12-month low of $81.51 and a 12-month high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The firm had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. During the same period in the prior year, the business earned $1.03 EPS. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. On average, analysts expect that Addus HomeCare will post 4.57 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Esteban Lopez sold 500 shares of the stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total transaction of $65,015.00. Following the transaction, the director now owns 3,866 shares of the company’s stock, valued at approximately $502,695.98. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total transaction of $65,015.00. Following the transaction, the director now directly owns 3,866 shares of the company’s stock, valued at approximately $502,695.98. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 22,917 shares of company stock valued at $3,050,082 over the last quarter. Insiders own 4.60% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

A number of institutional investors have recently made changes to their positions in the business. BNP Paribas Financial Markets grew its holdings in Addus HomeCare by 20.3% in the 1st quarter. BNP Paribas Financial Markets now owns 11,854 shares of the company’s stock valued at $1,225,000 after buying an additional 2,000 shares during the last quarter. Quantbot Technologies LP acquired a new stake in shares of Addus HomeCare in the first quarter worth $715,000. Empowered Funds LLC increased its position in Addus HomeCare by 9.8% during the first quarter. Empowered Funds LLC now owns 6,890 shares of the company’s stock worth $712,000 after acquiring an additional 615 shares during the period. TimesSquare Capital Management LLC raised its stake in Addus HomeCare by 9.8% during the 1st quarter. TimesSquare Capital Management LLC now owns 289,998 shares of the company’s stock valued at $29,968,000 after purchasing an additional 25,910 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its holdings in Addus HomeCare by 9.3% in the 1st quarter. Russell Investments Group Ltd. now owns 46,764 shares of the company’s stock valued at $4,833,000 after purchasing an additional 3,997 shares during the period. 95.35% of the stock is currently owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.